Compare CNTA & DAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CNTA | DAVE |
|---|---|---|
| Founded | 2020 | 2017 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.1B |
| IPO Year | 2021 | N/A |
| Metric | CNTA | DAVE |
|---|---|---|
| Price | $21.97 | $236.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 6 |
| Target Price | $37.70 | ★ $282.17 |
| AVG Volume (30 Days) | ★ 1.4M | 355.2K |
| Earning Date | 11-05-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 224.46 |
| EPS | N/A | ★ 10.12 |
| Revenue | $15,000,000.00 | ★ $491,301,000.00 |
| Revenue This Year | N/A | $56.88 |
| Revenue Next Year | N/A | $18.07 |
| P/E Ratio | ★ N/A | $23.20 |
| Revenue Growth | ★ 118.88 | 53.84 |
| 52 Week Low | $9.60 | $65.46 |
| 52 Week High | $30.58 | $286.45 |
| Indicator | CNTA | DAVE |
|---|---|---|
| Relative Strength Index (RSI) | 28.32 | 63.84 |
| Support Level | $22.15 | $208.15 |
| Resistance Level | $23.69 | $242.90 |
| Average True Range (ATR) | 1.03 | 11.48 |
| MACD | -0.36 | 2.36 |
| Stochastic Oscillator | 8.52 | 86.07 |
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.